Thyroid Cancer Metastasis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-03-29
Clinical Trial Update: Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas [Phase 2]
Phase 2 trial evaluating lenvatinib plus denosumab for predominantly bone metastatic radioiodine-refractory differentiated thyroid carcinoma…